This inventor holds 5 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: National Institutes for Quantum and Radiological Science and Technology, Eisai R&D Management Co., Ltd., National Institutes for Quantum Science and Technology. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 31 
1 out of 13 
1 out of 35 
Years Active: 2019-2026
Title: The Innovations of Meiei Cho
Introduction
Meiei Cho is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of imaging tau proteins that accumulate in the brain. With a total of four patents to his name, Cho's work is at the forefront of medical imaging technology.
Latest Patents
One of Cho's latest patents involves compounds for imaging tau proteins that accumulate in the brain. The invention provides a compound represented by a specific formula, which can be a pharmaceutically acceptable salt or a solvate. This compound serves as a molecular probe for imaging tau proteins, which are crucial for understanding various neurological conditions.
Career Highlights
Throughout his career, Meiei Cho has worked with esteemed organizations such as the National Institutes for Quantum and Radiological Science and Technology and the Public University Corporation Yokohama City University. His work in these institutions has allowed him to advance his research and contribute to significant innovations in medical imaging.
Collaborations
Cho has collaborated with notable colleagues, including Makoto Higuchi and Tetsuya Suhara. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Meiei Cho's contributions to the field of imaging tau proteins highlight his innovative spirit and dedication to advancing medical technology. His patents and collaborations reflect a commitment to improving our understanding of neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile